Allergan Settlement

AP News - 526 days ago
Allergan Settlement
Food and Drug Administration (FDA) Commissioner Margaret Hamburg, center, with Assistant Attorney General for the Civil Division Tony West, right, and U.S. Attorney for the Northern District of Georgia Sally Yates, left, speaks to reporters during a news conference at the Justice Department in Washington, Wednesday, Sept. 1, 2010, regarding a major settlement with a pharmaceutical company for False Claims Act and off-label marketing violations. Allergan Inc., the maker of wrinkle-smoothing Botox, has agreed to pay $600 million to settle a yearslong federal investigation into its marketing of the top-selling, botulin-based drug. (AP Photo/Manuel Balce Ceneta)